MoneyWorks4Me

The quarter ended June 2025 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 1540.67 millions.A humble growth in net profit of 16.91% reported in the quarter ended June 2025 to Rs. 276.75  millions from Rs. 236.72 millions.Operating Profit saw a handsome growth to 390.76 millions from 331.41 millions in the quarter ended June 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 1540.67 1472.82 4.61 1540.67 1472.82 4.61 6232.30 5805.50 7.35
Other Income 152.72 104.09 46.72 152.72 104.09 46.72 224.77 344.22 -34.70
PBIDT 390.76 331.41 17.91 390.76 331.41 17.91 1239.71 1343.30 -7.71
Interest 2.10 4.39 -52.16 2.10 4.39 -52.16 18.83 14.63 28.71
PBDT 388.66 327.02 18.85 388.66 327.02 18.85 1220.88 1328.67 -8.11
Depreciation 34.77 32.24 7.85 34.77 32.24 7.85 128.99 106.25 21.40
PBT 353.89 294.78 20.05 353.89 294.78 20.05 1091.89 1222.42 -10.68
TAX 77.14 58.06 32.86 77.14 58.06 32.86 268.42 289.38 -7.24
Deferred Tax 35.91 2.93 1125.60 35.91 2.93 1125.60 15.15 34.95 -56.65
PAT 276.75 236.72 16.91 276.75 236.72 16.91 823.47 933.04 -11.74
Equity 200.30 200.30 0.00 200.30 200.30 0.00 200.30 200.30 0.00
PBIDTM(%) 25.36 22.50 12.72 25.36 22.50 12.72 19.89 23.14 -14.03
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..